GlassScriptPhysician profile
Mani Khaleghi
NPI 1275072423
$4,889.14
in general payments reported to CMS, 2019-2025
25 companies · $1,819 in 2025
The $1,819 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $199 · 2022: $308 · 2023: $718 · 2024: $1,845 · 2025: $1,819.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,382.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $994.14 | 2023-2025 | Prolate, Nalocet, Tanlor |
| Collegium Pharmaceutical, INC. | $656.04 | 2022-2025 | Belbuca, Xtampza |
| Boston Scientific Corporation | $537.16 | 2021-2025 | General - Pain Management, Wavewriter Alpha Prime 16, Intracept |
| Nevro Corp. | $444.03 | 2023-2024 | Senza |
| Curonix LLC | $415.14 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $335.14 | 2022-2025 | Relistor |
| Axonics, INC. | $289.21 | 2024 | Axonics |
| Scilex Pharmaceuticals INC. | $213.19 | 2023-2025 | Ztlido |
| Vertos Medical, INC. | $170.88 | 2024 | Mild Device Kit |
| Si-Bone, INC. | $166.51 | 2025 | |
| Pharmacyclics LLC, An Abbvie Company | $141.84 | 2021-2023 | Imbruvica |
| Stryker Corporation | $101.44 | 2025 | Mild Device Kit |
| Foundation Fusion Solutions, LLC | $64.60 | 2024 | |
| Azurity Pharmaceuticals, INC. | $48.32 | 2023-2024 | Horizant, Horizant |
| Grt US Holding, INC. | $45.00 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $41.24 | 2024 | |
| Beigene USA, INC. | $32.35 | 2021 | |
| Nalu Medical, INC. | $31.32 | 2024 | Nalu Neurostimulation System |
| Medtronic, INC. | $29.48 | 2024 | Intellis Adaptivestim |
| Axsome Therapeutics, INC. | $28.37 | 2025 | Symbravo |
| Amgen INC. | $25.26 | 2022 | |
| Globus Medical, INC. | $22.61 | 2025 | Omnia |
| Dova Pharmaceuticals | $20.84 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $19.30 | 2025 | Ajovy |
| Tonix Medicines, INC. | $15.73 | 2025 | Tonmya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mani Khaleghi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.